Figure S3 - PLOS

Recommend Documents

Figure S3. Neutralization titres against H1N1pdm. The location of each pie chart indicates neutralization tire at baseline (x-axis) and at follow-up (y-axis).

Figure S3 - PLOS

Page 1. BRCA1. FANCA. BARD1. CHK2. BRCA2. FANCF. ERBB2. FANCD2. FANCB. TP53. MLH1. ITGB3BP. Figure S3.

Figure S3 - PLOS

Page 1. 0. 10. 20. 30. 40. 50. 60. 70. HIF004Bay x. HIF004Sha. R e la tive. P rim a ry R o o t le n g th. (%. ) HIF004Bay. HIF004Sha a a b. Figure S3.

Figure S3 - PLOS

Mobility of TTDA with and without actD. 0. 10. 20. 30. 40. 50. 0.4. 0.6. 0.8. 1.0. Time (sec.) R e la tiv e flu o rescenc e. Figure S3.

figure s3 - PLOS

FIGURE S3. Homer la Knockout. Oh. 48 h. 200%. |. UH. NREM Delta %. Days. 20 IL. 09%. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15. Interval. --WT HE HET O-KO.

Figure S3 - PLOS

Figure S3. - PLOS

Figure S3 - PLOS

Figure S3. - PLOS

DQ138152 VIET NAMA/CHICKEN/VIET NAM/TG-023/2004 GALLIFORMES. DQ138153 VIET NAM A/CHICKEN/VIETNAM/LA-024/2004 GALLIFORMES.

Figure S3 - PLOS

Supplementary Figure S3 - PLOS

Figure S3.pptx - PLOS

C. D. 1. 4. /1. 9. A le x a. -7. 0. 0. 0. 0. 50K. 100K. 150K. 200K. 250K. SSC-A. 85.5. 0. 10 3. 10 4. 10 5. C. D. 3. A. P. C. -H. 7. 0. 50K. 100K. 150K. 200K. 250K.

Figure S3 - PLOS

1.0. 0.9. 0.8. 0.7. 0.6. 0.5. 0.4. 0.3. 0.2. 0.1. 0. 10-3. 10-2. 10-1. 100. 101. 102. 103. Legend. Log10(S15) (nM). Fraction B ound. Rr-mRNA. 1.0. 0.9. 0.8. 0.7. 0.6.

Figure S3 - PLOS

ABCDE Figure S3 - PLOS

All coasts, with Chipewyan, Cree, Ojibwa, Ache, Guarani, Kaingang excluded. 0. 0.1. 0.2. 0.3. 0.4. 0.5. 1: 0. 0. 5. 1: 0. 0. 4. 1: 0. 0. 3. 1: 0. 0. 2. 1: 0. 0. 1. 1: 0. 5. 1:.

Figure S3 - PLOS

GM-10. AN-30. S-10. N-30. NN-10. LZD-30. TE-5. MI-30. D-30. T-30. TGC-15. NB-30. ENX-10. GAT-5. CIP-5. LOM-10. SPX-5. LVX-5. MFX-5. EM-50. Figure S3.

Figure S3 - PLOS

3. 4. 5. 6. 7. 8. 0.50. 0.75. 1.00. 1.25. 1.50. Peak 2b. Peak 2a. AUC =Area under the curve. Peak 1. Age in months. A. UC. (A. U). Figure S3. 0. 5. 10. 15. 20. 25. 0.

Figure S3. - PLOS

Figure S3. Additional structures tested in this study. Compound Name. Screen Name. CAS #. Structure. 5-(3-Pyridyl)-4H-1,2,4-triazole-3- thiol. OLC16.

Figure S3. - PLOS

Figure S3 - PLOS

Download PDF

0 downloads 0 Views 2MB Size Report

Comment

FIGURE S3 perinuclear region lamellar region. (Î¼ m. 2. ) 10-3. 10-2. 10-1. 100. 10-3. 10-2. 10-1. 100. Time Lag, Ï (s). 10-1. 100. 101.

FIGURE S3 A

10 0

B

1

(µm2)

perinuclear region 2

3 lamellar region

10 0

Perinuclear Lamellar All

10 -1

10 -1

1 10 -2

10 -2

3

10 -3 10 -1

10

10 -3

10 1

0

Time Lag, τ (s) C

10 0

10 0

D

0.125

Perinuclear

+Blebbistatin 10 -1

+ML-7

(µm2)

(µm2)

Control 10 -1

1 10 -2

10 -2

Perinuclear 10 -3 10 -1

10 -3

10 0

0.100 0.075

+Blebbistatin +ML-7

0.050 0.025 0

10 1

Control

10 0

10 0

0.125

F

Lamellar

+Blebbistatin 10 -1

+ML-7

1 10 -2

10 -2

Lamellar 10 10 -1 -3

10 0

Time Lag, τ (s)

10 -3

10 1

(µm2)

(µm2)

Control 10 -1

10 1

Time Lag, τ (s)

Time Lag, τ (s) E

10 0

10 -1

0.100 0.075

Control +Blebbistatin +ML-7

0.050 0.025 0

10 -1

10 0

Time Lag, τ (s)

10 1